With the EU HTA Regulation now in force (January 2025), this session will explore the critical need to account for vaccines specificities in the implementation of the EU HTA Regulation to optimise their access and impact on public health, economy and society across Europe and globally. This session will also present the key findings from the peer-reviewed publication “Guiding Principles for Evaluating Vaccines in Joint Health Technology Assessment in the EU”, co-authored with leading European vaccine experts.